Research demonstrates the potential of the Parsortix® system to support powerful characterisation of CTCs in head and neck cancer.
New publication!
Latest report
Annual Report December 2023
Please click the links below to download our Annual and Interim Reports and Financial Statements
Open PDFFor any investor relations queries please contact
investor@angleplc.comFor any investor relations queries please contact
investor@angleplc.com